Cargando…
Alzheimer's disease progression and risk factors: A standardized comparison between six large data sets
There exist a large number of cohort studies that have been used to identify genetic and biological risk factors for developing Alzheimer's disease (AD). However, there is a disagreement between studies as to how strongly these risk factors affect the rate of progression through diagnostic grou...
Autores principales: | Evans, Stephanie, McRae-McKee, Kevin, Hadjichrysanthou, Christoforos, Wong, Mei Mei, Ames, David, Lopez, Oscar, de Wolf, Frank, Anderson, Roy M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804515/ https://www.ncbi.nlm.nih.gov/pubmed/31650008 http://dx.doi.org/10.1016/j.trci.2019.04.005 |
Ejemplares similares
-
The importance of endpoint selection: How effective does a drug need to be for success in a clinical trial of a possible Alzheimer’s disease treatment?
por: Evans, Stephanie, et al.
Publicado: (2018) -
The dynamics of biomarkers across the clinical spectrum of Alzheimer’s disease
por: Hadjichrysanthou, Christoforos, et al.
Publicado: (2020) -
Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal Studies
por: Hadjichrysanthou, Christoforos, et al.
Publicado: (2018) -
Association of TDP-43 proteinopathy, cerebral amyloid angiopathy, and Lewy bodies with cognitive impairment in individuals with or without Alzheimer’s disease neuropathology
por: Thomas, David X., et al.
Publicado: (2020) -
Combining hippocampal volume metrics to better understand Alzheimer’s disease progression in at-risk individuals
por: McRae-McKee, K., et al.
Publicado: (2019)